bibliographic resource 1365207 [br/1365207]
https://w3id.org/oc/corpus/br/1365207
- is a
-
- title
-
- Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52Â weeks: a phase III, randomized controlled trial (ESTEEM 2)
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-